Introduction
Compared to developmental biology studies in lower organisms, such as Caenorhabditis elegans and zebrafish, the mouse presents significant challenges for direct visualization and analysis of volumetric and dynamic changes in embryos and their developing organ systems. Despite advances in optical microscopy and the availability of mouse reporter lines expressing fluorescent proteins, in vivo optical imaging is generally restricted to tissue explants and exo utero imaging of early-stage embryos that are amenable to whole embryo culture, and imaging studies cover relatively short time windows over which normal development can be maintained. Ultrasound and magnetic resonance imaging (MRI) are widely used for human fetal and pediatric imaging, and can be scaled to provide effective microimaging tools for application in mice. Although the spatial resolution of these methods (typically 50-100 m) is lower than optical microscopy, they offer the advantages of much greater penetration, enabling whole body imaging, and the ability to perform three-dimensional (3D) anatomical and functional phenotype analyses, including noninvasive longitudinal imaging over periods of days to weeks, both in utero in mouse embryos, and extending to neonatal through adult stages of organ development. A major challenge for imaging methods, including ultrasound and MRI, is the need for high image throughput necessary to match the requirements for efficient phenotypic screening of mutant and transgenic embryos and postnatal mice. In this context, both ultrasound and MRI offer significant advantages in terms of real-time imaging capability (ultrasound) and the recent development of multiple-mouse imaging systems (MRI). For phenotype screening with either method, the image analysis process is critically important, but is not discussed in detail in this chapter. It is worth noting that MRI data are particularly well-suited to computational 3D analysis approaches, providing the potential to greatly improve phenotyping throughput and detection of more subtle changes than can be evaluated by simple inspection of images. Such methods have produced impressive results in the adult mouse brain (Lerch et al., 2008; Nieman et al., 2006) , but have not been employed extensively to date for analysis during development or in other tissues. In principle, however, these and emerging methods can be extended to provide embryonic and neonatal phenotype analysis. Development of such automated phenotyping methods are likely to continue, particularly in the context of embryo imaging, as large-scale efforts to generate mutants of every gene motivate improved high-throughput phenotyping methods. It should also be noted that ultrasound and MRI are two technologies among others that provide similar, often complementary information. Alternative techniques not described here include X-ray computed tomography after iodine staining or perfusion of X-ray opaque vascular agents (Marxen et al., 2004; Metscher, 2009 ) and optical projection tomography, which advantageously may also permit the use of immunohistochemical fluorescent markers (Sharpe et al., 2002; Walls et al., 2008) . Ultrasound and MRI are notable for their ability to provide in vivo data in mouse embryos.
With the recent increase in multimodality small-animal imaging facilities in many research centers, the ability to utilize ultrasound and MRI microimaging is now a reality for many mouse developmental biologists. In this chapter, we describe a variety of ultrasound and MRI methods that are now available for studies of mouse development.
Ultrasound Biomicroscopy
Ultrasound is the most common approach for fetal imaging in the clinic. Likewise, ultrasound biomicroscopy (UBM) is now a wellestablished method for in utero imaging of mouse embryos (Srinivasan et al., 1998; Turnbull et al., 1995; reviewed in Turnbull and Foster, 2002) . UBM is a high-frequency (30-100 MHz) form of pulse-echo imaging, providing high-resolution (30-100 m) images in real time. Highfrequency Doppler ultrasound has also been incorporated into UBM scanners to measure blood velocity, originally using separate transducers for imaging and Doppler ( Fig. 21.1) , and more recently with both functions provided by the same transducer in commercial scanners (Foster et al., 2009; Zhou et al., 2002) . Originally, UBM systems were based on single, mechanically scanned transducers, but more recently array transducers have been developed to improve focusing (Aristizabal et al., 2006) and increase image frame rates using electronic beam forming without the need for mechanical scanning (Foster et al., 2009) . In utero UBM of mouse embryos is most commonly performed at frequencies between 40 and 50 MHz, which allows sufficient penetration to image mouse embryos throughout gestation with high spatial resolution, starting from early postimplantation stages (Zhou et al., 2002) .
UBM of mouse embryos and neonates
Since its introduction for in utero mouse embryo imaging over 15 years ago, UBM has found numerous applications, mostly for brain and cardiovascular imaging (reviewed in Turnbull and Foster, 2002) . Similar to clinical ultrasound, Doppler approaches have enabled analysis of blood flow properties in the embryo that provide new insights into development of cardiovascular function (reviewed in Phoon and Turnbull, 2003) . The general approach taken for in utero UBM studies is to anesthetize the pregnant mouse, remove the hair on the skin overlying the embryos, and couple the UBM transducer to the mouse using a commercially available ultrasound gel, or a holding system that incorporates a water bath between the transducer and the skin (Fig. 21.1 ). Two-dimensional (2D) UBM images are acquired in real time (!100 images/s with current technology), and 3D imaging can be accomplished by acquiring a stack of 2D UBM images (Aristizabal et al., 2006) . Recently, commercial UBM scanners have also included color flow imaging, in which Doppler signals are analyzed in real time to produce a color-coded map of blood velocities (Foster et al., 2009) .
To date, UBM has found greatest application in the mouse cardiovascular system, although similar techniques should provide data relevant to many organ systems. UBM and UBM-Doppler methods can be used over a very wide range of cardiovascular developmental stages ( Fig. 21.2) , from the onset of heart beat at E8.0 (Ji et al., 2003) , through the critical early stages of chamber formation between E10.5 and E14.5 (Phoon et al., 2000 (Phoon et al., , 2002 Srinivasan et al., 1998; Zhou et al., 2003) , and into neonatal stages when cardiomyopathy and heart failure are first manifested in many mutants (Fatkin et al., 1999 phenotyping NFATc1 À/À mutants, which lack aortic and pulmonary cardiac valves and die in utero, revealed unusual mechanisms of embryonic heart failure (Phoon et al., 2004) . Longitudinal studies of each embryo in a pregnant mouse, required for effective in utero phenotype analysis with UBM, is challenging but can be achieved through careful mapping of extra-and intraembryonic anatomical landmarks to enable accurate identification of individual embryos over a period of several days ( Ji and Phoon, 2005) .
In utero UBM-guided injections
For over a decade, UBM has provided a unique and powerful approach for direct in utero image-guided manipulation of mouse embryos (Liu et al., 1998; Olsson et al., 1997) . This has been most utilized in the developing embryonic brain, where UBM-guided injections have enabled in utero neural cell transplantation (Butt et al., 2005; Olsson et al., 1997; Wichterle et al., 2001) , cell lineage tracing (Kimmel et al., 2000) , and gain-of-function studies with retroviruses or electroporation (Gaiano et al., 1999; Punzo and Cepko, 2008; Weiner et al., 2002) . For UBM-guided injections, timed pregnant mice are anesthetized with nembutol or isoflurane, and the uterus exposed after laparotomy (Fig. 21.3 removed from the lower abdominal skin, and a midline incision made through the skin and peritoneum. The pregnant mouse is laid supine in the lower section of a two-level stage, and a plastic Petri dish, modified by punching a $25 mm diameter central hole, is secured over her abdomen. Part of the uterus containing one to two embryos (depending on embryonic stage) is gently pulled through a slot, cut into a thin rubber membrane stretched across the hole in the Petri dish, into sterile PBS. The UBM transducer is then lowered into the PBS bath, providing real-time imaging of the mouse brain and image-guidance of a pulled and sharpened 50-m diameter glass microcapillary injection needle, mounted on a 3D micromanipulator and inserted through the uterine wall and into the embryonic target region (Fig. 21.4 ). After injection, one to two new embryos are gently pulled into the PBS, and the injected embryos gently placed back through the slot into the abdominal cavity. In this way, an entire litter (8-10 embryos) can be injected in $1 h, after which the muscle and skin are sutured or clipped and the pregnant mouse recovers in a warming chamber until regaining consciousness. Like most surgical procedures, survival of embryos is operator-dependent, but most people can achieve at least 50-60% embryonic survival after practice, and many can reach 80% survival or better for in utero brain injections. In addition to the applications described above, UBM-guided injection can also provide a unique method for precise targeting of cell-labeling agents in mouse embryos, for example, with MRI contrast agents that label cells that can then be followed with longitudinal MRI imaging.
Magnetic Resonance Microimaging
MRI is well-established in clinical radiology as an imaging tool that provides excellent soft tissue contrast for isolating pathologies or characterizing anatomy. Increasingly, MRI is also used for assessment of functional parameters, such as blood perfusion, oxygenation status, or cardiac dynamics, and in larger population studies to identify regions altered by disease or development (Aljabar et al., 2008; Davatzikos et al., 2005; Janke et al., 2001) . MRI, like ultrasound, can be scaled down for magnetic resonance microimaging (micro-MRI), providing a powerful quantitative approach for assessing changes in 3D anatomy and physiology during development, including isolating phenotypes in genetically modified mice. Compared to UBM, micro-MRI image contrast is remarkably flexible, allowing optimization of image acquisition to highlight anatomy or pathology of interest. The MRI signal is ultimately derived from the perturbed magnetic state of water protons within the tissue; however, variations in the acquisition can emphasize image contrast from different physical processes affecting the proton signal. Traditional images are referred to as protondensity-, T 1 -, or T 2 -weighted images, according to the mechanism most reflected in the image contrast. However, diffusion, perfusion, blood flow or macromolecular content can also provide a basis for image contrast, and may be preferred in many applications in developmental biology studies. Administration of contrast agents that produce hyper-or hypointensity in an image is also prevalent, and particularly common in mouse imaging, both for in vivo and ex vivo imaging studies. This contrast flexibility provides opportunities in research to highlight physiology, anatomy, and even molecular/cellular regions of interest.
Typical resolutions achieved with in vivo micro-MRI are on the order of 100 m in adult mice. The reduced size of the embryo, particularly during early developmental stages, requires higher resolution for visualization of anatomical features. This limitation has meant that MRI imaging has been most feasible in mid-to late-embryonic stages, starting around E12. Likewise, there has been a preference for studying embryos with ex vivo micro-MRI, where specimen imaging hardware and longer acquisition times can be tailored to achieve the necessary resolution increase without the concerns for anesthesia and animal maintenance necessary in vivo. Nevertheless, in vivo micro-MRI methods are particularly beneficial for examining earlypostnatal mice, when the phenotype permits, and continued development of in utero imaging methods shows potential for more widespread in utero studies in the future.
Below we describe methods for both ex vivo and in vivo micro-MRI of mouse development (Turnbull and Mori, 2007) . Developmental MRI studies to date have focused primarily on the heart, brain, or vascular systems and so these areas are highlighted in this chapter. This is, however, in part a reflection of the developmental biology community at large and should not be considered an inherent limitation of the technology. Indeed, with a high demand for phenotyping mice, and a large number of embryonic lethal phenotypes, continued development of embryo phenotyping tools will remain a priority.
Ex vivo anatomical micro-MRI
Although one of the frequently cited benefits of MRI is its in vivo potential, ex vivo images provide exquisite spatial resolution for detection of phenotypes at defined time points. This permits a more detailed anatomical comparison between mutant and wild-type groups for detection of subtle phenotypes. Ex vivo images generally run for many hours in an ''overnight'' scan session, achieving spatial resolutions between 20 and 50 m. These images can be acquired on a routine basis, and are highly appropriate for screening new mutants and performing volumetric structural analyses of phenotypes ( Fig. 21.5 ; Petiet et al., 2008) .
Ex vivo imaging requires fixation and mounting of embryonic specimens for micro-MRI. Mouse embryos are harvested at a defined stage, where by convention noon of the day after mating is defined as embryonic day 0.5 (E0.5). After extraction from the uterus, embryos are immersed overnight or longer in 4% paraformaldehyde (PFA) or equivalent for fixation at 4 C. For mid-to late-stage embryos, embryos can also be perfusion-fixed for improved fixation, and for vascular imaging, as described below. Prior to imaging, specimens are embedded in 1-3% agar or immersed in a protonfree fluid, such as Fomblin (Ausimount) or Fluorinert (3 M). Some investigators also report ''doping'' the agar either proton-free fluid or an ironoxide contrast agent in order to reduce the background agar signal in the image (Dhenain et al., 2001) .
For imaging, prepared sample tubes are placed within radiofrequency coils that collect the proton signal used to reconstruct images. Small solenoid coils ($10 mm diameter, $15 mm length) that fit closely around individual sample tubes provide optimal detection of the water proton signal and signal-to-noise ratio, a common metric of image quality. However, high-resolution ex vivo scans commonly require many hours and are run in ''overnight'' scan sessions, so imaging one embryo per evening can be prohibitively slow. In the aim of increasing throughput, multiple samples can be embedded in larger tubes and placed in a single larger coil, and then imaged collectively (Schneider et al., 2004) . This results in one large image, from which individual, 3D images containing single specimens can be extracted. An alternative method for increasing throughput is offered in specialized MRI systems equipped for multiple-mouse MRI (Bock et al., 2003) . This technology enables many imaging experiments to be run in parallel, utilizing several single-specimen solenoid coils with one specimen each and avoiding any compromise in image quality-an unavoidable consequence of using a single larger coil.
With either hardware configuration, image acquisition must be prescribed to achieve the desired contrast. It is common to perform a refinement of imaging parameters to achieve the contrast optimal for a particular application. For general anatomical discrimination at high-field (!7 T), T 2 -weighted imaging is generally preferred (Dhenain et al., 2001) , and can be achieved in fixed samples using repetition time (TR) ! 2000 ms and echo time (TE) $35 ms. Improved acquisition efficiency can be achieved by adding modest concentrations of MRI contrast agent-most commonly gadolinium compounds such as DTPA-Gd or DOTA-Gd-to the fixative and storage solutions. This serves to increase the rate of water proton signal dynamics, thereby allowing for either shorter imaging sessions or higher resolution images. A concentration of 2 mM Gd-chelate in the fixative, for instance, in combination with TR $ 300 ms and TE $ 35 ms retains excellent T 2 -weighted contrast in a fraction of the acquisition time. Alternatively, more highly doped samples (with !30 mM Gd-chelate, for instance) may allow more rapid imaging (Johnson et al., 2007) , with TR and TE reduced to $50 and $5 ms. In the latter case, contrast is heavily dependent on contrast agent distribution and diligence ensuring consistent specimen preparation is paramount. Modest concentrations of contrast agent ( 3 mM Gd-chelate) are also beneficial for diffusion tensor imaging (described below), but higher concentrations confound measurements of the diffusion related signal effects. Methods for evaluating mouse embryo development with ex vivo micro-MRI have been available for over a decade (Smith et al., 1996) , with continued improvements resulting in atlases of mouse development from as early as E6.5, and with resolutions $20 m (Dhenain et al., 2001; Petiet et al., 2008) . Micro-MRI shows potential for phenotyping of embryos in developmental studies (Schneider et al., 2003b) , and has been particularly successful in studying cardiac morphology and structure (Smith, 2001) . The heart, with its several chambers and intertwining inflow and outflow tracts, is a structure that can be very difficult to appreciate using traditional histological sections and is best-visualized with 3D imaging methods. These features have been helpful in phenotyping of the Cited2 and Cx43 mutants, identifying atrial and ventricular septal defects, inflow and outflow tract abnormalities, and aortic arch malformations (Schneider et al., 2003a; Wadghiri et al., 2007) . Phenotyping has also been performed in the brain, revealing changes associated with ethanol or retinoic acid administration during pregnancy (Parnell et al., 2009) , and a preliminary study investigating study of bone development has also been reported (Ichikawa et al., 2004) .
Despite these successes, micro-MRI for study in development has not been used as widely as might be expected. MR scanner availability and challenges associated with analyzing large 3D image data sets in a systematic and efficient way have likely been among the historical barriers. In this regard, analysis of the resulting images for possible phenotypes is a crucial step, one that cannot be treated fully here. The processing steps depend largely on the phenotypes in question. Anatomical phenotypes remain the most commonly investigated by micro-MRI and are appropriate for initial investigations and general characterizations of new mutants. Gross phenotypes can be detected by simple inspection of images, and are of sufficient severity that further analysis provides little additional insight. In many instances, more subtle anatomical differences are present. In these cases, segmentation of structural volumes or computational analysis of local volume/shape changes is necessary to describe the anatomical phenotype. These analysis methods, while employed extensively in adult mouse brain, have had more limited application in developmental studies. However, the tools are not inherently limited to adults, and are beginning to be applied more widely in the embryo and neonate as imaging methods are refined. In general, anatomical phenotypes are very common in genetic mutants (Nieman et al., 2007) , so results are likely to be plentiful and micro-MRI provides an important starting point for further investigation.
Ex vivo diffusion tensor imaging
Some anatomical features in embryos, particularly in the central nervous system, are difficult to visualize with traditional MRI contrast weighting. White matter, for instance, which exhibits prominent contrast in later stages, is still under development in embryonic stages so that brain structures myelinated in the adult can be difficult to visualize in the embryonic brain. Novel contrast mechanisms based on water diffusion properties enable enhanced contrast of these structures, and further-through a method called diffusion tensor imaging (DTI)-provide data for computation of the preferential diffusion directions associated with the presence of axons or other anisotropic structures. DTI methods can be used in the postnatal human brain, and show great potential for MR-based phenotyping in the embryonic mouse brain.
DTI data is generally computed based on a set of six or more diffusionweighted images in addition to a reference, minimally diffusion-weighted (e.g., T 2 -weighted) image. The degree of diffusion weighting is controlled in the scan by adjusting a parameter called the b-value. Diffusion-weighted images are typically acquired with b ¼ 1000-1500 s/mm 2 . The low diffusion reference image is generally acquired with a nominal value of b ¼ 0 s/mm 2 , although higher values (b $ 200 s/mm 2 ) have been used in fixed samples where some suppression of background signal from the embedding medium is desirable (Mori et al., 2001) . As each separate diffusion-weighted image requires as long or longer than an individual anatomical image (such as a T 2 -weighted image), acquisition time in DTI studies is often a limiting factor.
The fixation of embryos for DTI-MRI may be performed as described above for standard ex vivo imaging. The use of contrast agents during fixation can also be beneficial for speeding image acquisition, but only modest concentrations ( 3 mM Gd-chelate) are appropriate as high concentrations of contrast agents may confound measurements of the diffusion related signal effects. While absolute measures of diffusion measured in fixed specimens differ from measurements in the in vivo case (Shepherd et al., 2009; Sun et al., 2009) , relative measures including the principal diffusion directions are not altered (Kim et al., 2009; Sun et al., 2003) .
After collection of the necessary images, it is common to process the images to produce a map representing diffusion properties in the brain. In the simplest case, a map showing the degree of anisotropy-the extent to which there is a preferred diffusion direction-can be produced and shown in a simple gray scale image, providing a novel anatomical map emphasizing structures altering water diffusion. To show the principle diffusion direction on DTI images, a color map convention for visualization of DTI data sets has emerged in which the medial-lateral, dorsal-ventral, and rostral-caudal directions are each represented as one of the red, green, or blue channels in an RGB color space. The intensity of the colors can then be modulated by the degree of anisotropy, fading to black for isotropic diffusion and appearing at full intensity for directional diffusion. Both MRI system manufacturer and independent software is available for the computation of the DTI maps from the raw diffusion-weighted imaging data.
DTI maps are particularly powerful for micro-MRI of mouse brain development (Fig. 21.6 ). Defects in the formation of key white matter structures including the corpus callosum and the hippocampal commissure, as in Robo1 and Netrin1 mutants, can be analyzed (Andrews et al., 2006; Zhang et al., 2003) . Similarly, apparent degeneration of white matter structures-the fimbria and commissures-has been reported during postnatal development (Zhang et al., 2005a) . In addition to enhancing white matter conspicuity, DTI maps also provide surprising contrast in the neocortex of developing embryos (Mori et al., 2001) . Methods for automated analysis based on diffeomorphic mapping in DTI-derived maps have also been reported (Zhang et al., 2005b) , suggesting routine automated screening and analysis could be developed.
Ex vivo vascular imaging
A sensitive method for vascular imaging in ex vivo embryo specimens requires perfusion with an intravascular contrast agent, such as DTPA-Gd conjugated to albumen. For this, the umbilical vessels are isolated for cannulation and perfusion-fixation after exteriorizing the embryo from the uterus and yolk sac (Smith et al., 1994 (Smith et al., , 1996 . The intravascular contrast agent is mixed in gelatin solution and perfused into the embryo after flushing the blood and fixative solutions, after which the umbilical vessels are tied off and the embryo is further immersion fixed as described above (without contrast agent). Imaging then proceeds with a T 1 -weighted imaging sequence (TR 50 ms; TE 5 ms), producing bright blood vessels in the presence of the intravascular contrast agent (Fig. 21.7) .
The benefit of 3D imaging is particularly important for analysis of the vascular system. The branching, tree-like structure of the vasculature cannot be captured in 2D histological sections, making 3D methods a necessity. In some cases, important findings can be overlooked in traditional histology or pathology due to the difficulty in assessing the entire vascular tree. For example, the deletion of basilar artery in Gli2 À/À mutants was only noticed during micro-MRI analysis ( Fig. 21.7 ; Berrios-Otero et al., 2009). Similarly, micro-MRI of Connexin43 mutant mice revealed abnormal development of both the right ventricle and major outflow tracts, difficult to appreciate from histological analysis (Huang et al., 1998; Wadghiri et al., 2007) .
In vivo micro-MRI of mouse embryos and neonates
In vivo micro-MRI offers unique opportunities to assess longitudinal development and functional parameters such as blood perfusion, heart motion, or other physiological measures. In vivo studies can also be convenient in the context of comprehensive phenotyping studies, in which several additional In this case, white, yellow, pink, and blue arrowheads indicate the optic chiasm, hippocampal commissure, anterior commissure, and corpus callosum, respectively. Asterisks (*) mark the neuroepithelium around the third ventricle. All data are from full three-dimensional data sets. Reprinted from Zhang et al. (2003) with permission.
assays are required following initial imaging assessment, or in the case of conditional mutants, where variably penetrant phenotypes motivate detailed, time course imaging of individual animals. However, in vivo micro-MRI during development has been historically challenging. The small size of embryonic and neonatal mice requires high-resolution images, and consequently long scan times. The mice must be anesthetized throughout this period, and physiological monitoring and peripheral heating must be employed to ensure proper maintenance of their health. Physiological and other motion during the scans-detrimental to image quality-must be eliminated or compensated.
In vivo micro-MRI has been applied successfully in neonatal mice. Although the small size of neonates makes positioning and restraint challenging, good results can be achieved provided dedicated neonate cradles and setups similar to those used for adult mouse imaging. Isoflurane gas is the preferred method of anesthesia. After induction at 4-5%, animals can be maintained at $1% isoflurane concentration for extended time periods (up to $3 h). During this time, body temperature should be maintained with external heat sources and physiological signs must be monitored. Small ECG electrodes have been employed in mice as early as 3 days after birth, timing the acquisition of MRI data to the phase of the heart cycle to allow excellent visualization of the heart via prospectively gated cine-MRI methods (Wiesmann et al., 2000) . Despite these successes, physiological monitoring can be a challenging aspect of working with neonates. Detection of respiratory or cardiac events using additional data acquired from the MRI scanner itself has been shown as an alternate method for detection of physiological events, and in our experience can greatly improve the efficiency of setup for neonate imaging, without compromising monitoring capability during the 3D imaging session . Repeated in vivo imaging of individual mice postnatally provides a measure of brain development, mapping regions of the most rapid growth quantitatively ( Fig. 21.8 ). Longitudinal growth maps through several time points can provide a quantitative picture of the growth process from birth through adulthood. Comparisons of in vivo images of neonatal mice with different genotypes have also demonstrated potential for phenotyping, visualizing, for instance, abnormalities in the Gbx2 mutant cerebellum ( Fig. 21.5 ; Wadghiri et al., 2004) .
Imaging the embryo in utero has been more limited, largely because it is not possible to reliably keep the embryo from moving inside the maternal abdomen. While neonates-with extra care and dedicated hardware-can be handled with similar procedures as adult animals, embryos in utero cannot be
P09
Overlay P11 Jacobian growth map 1.0 1.5 Figure 21 .8 Computational mapping of growth in the developing mouse brain. In vivo Mn-enhanced MRI images at days 9 and 11 after birth (left and rightmost columns, respectively) provide a visual representation of growth-related changes. Computational image processing can provide a quantitative growth map (second column). An overlay of the growth map on the outline of the P09 mouse shows that the most significant growth is occurring in the cerebellum and regions of the cortex.
restrained or monitored in the same fashion. One solution to this challenge is to image more quickly, using rapid acquisition of 2D slices rather than acquisition of high-resolution 3D volumes. This method has been applied successfully by several groups (Chapon et al., 2002; Hogers et al., 2000) using a T 2 -weighted spin-echo imaging sequence, including one example in which in utero imaging could distinguish between genotypes in embryos transgenically expressing human ferritin (Cohen et al., 2007) . However, the 2D rapid MR images provide very limited image detail and lack sufficient anatomical data to investigate any but the most obvious phenotypes. Imaging methods that permit acquisition of high-resolution 3D volumes in the presence of motion should permit much improved study of the live embryo in utero. In late-embryonic stages, where the resolution capabilities of MRI may be satisfactory, movement is somewhat restricted relative to earlier stages, so only a small amount of motion need be accounted for. We have found that gating on maternal respiratory motion, in combination with manganese (Mn) enhancement via maternal i.p. injection of MnCl 2 , can provide high-quality in utero T 1 -weighted images, enabling volumetric analysis of ventral forebrain defects in Nkx2.1 À/À mutant embryos (Deans et al., 2008) . For additional motion compensation, prescription of a series of rapid 3D volume acquisitions (with 3-5 min acquisition time per image) provides images with sufficient quality to detect image motion between serially acquired images. In postprocessing, therefore, a set of serial images can be corrected for motion and then combined to produce high-quality image reconstructions. In combination with detection of cardiac motion, we have shown that this method can even be used to produce images of the beating embryonic heart ( Fig. 21.9 ; Nieman et al., 2009) .
Further improvements for in utero imaging will broaden the potential application of these emerging methods. Most notably, dedicated hardware configurations for in utero imaging will be necessary to enhance imaging results sufficiently for routine application. Dedicated coil arrays, for instance, may improve the imaging outcome, allowing large field-of-view pilots to isolate individual embryos and yet still offer the sensitivity of a small surface coil for small field-of-view embryo imaging. Isotropic resolution close to 70 m would likely be sufficient for many developmental studies, commencing in mid-to late-embryonic stages. Nonetheless, the complications associated with in utero imaging will mean it is not likely to serve the same screening role as ex vivo imaging, but will rather be used for assessing particular phenotypes requiring longitudinal examination. Important applications for in utero imaging include the evaluation of developmental changes that occur between late-embryonic and early-postnatal stages, functional measurements (such as cardiac performance or blood perfusion) in embryos with mutations lethal in late-embryonic stages, and time course studies of developmental abnormalities during maternal exposure to toxins.
Summary
UBM and micro-MRI are microimaging techniques based on ultrasound and magnetic resonance, respectively, that provide powerful new approaches for anatomical and functional phenotype analysis in developing mouse embryos and neonates. UBM provides real-time image acquisition and Doppler blood velocity measurements, which has been widely used for studies of brain and cardiovascular development, and as a method for in utero imageguided injections. Micro-MRI has more flexibility for image contrast compared to UBM, but requires longer acquisition times. Micro-MRI of multiple fixed mouse embryos can be applied in a relatively high-throughput manner, with and without contrast agents, to analyze a wide range of phenotypes. In addition to these more conventional MRI methods, diffusion-weighted MRI and DTI have been demonstrated for 3D analysis of tissue microstructure and connectivity that is difficult to appreciate with standard histological analysis. Finally, recent advances have shown the feasibility of using micro-MRI for in utero imaging in live mouse embryos, providing the potential for future longitudinal studies of individual mice from embryonic to adult stages. figures from their published work. We are grateful to all our current and past students, postdocs, and colleagues at the Mouse Imaging Centre and the Skirball Institute of Biomolecular Medicine who contributed to the work described in this chapter. We especially thank Kamila Szulc who provided the micro-MRI data used to compute the developmental growth map shown in Fig. 21 .8. Some of the research described in this chapter was supported by grants from the National Institutes of Health (R01 NS038461, R01 HL078665) and contracts from the New York State Department of Health (C022053, C020926).
